ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
3 |
01/04/23 |
01/04/23 |
ASX - By Stock
|
1.2K
|
435K
|
3
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
0 |
01/04/23 |
01/04/23 |
ASX - By Stock
|
1.2K
|
435K
|
0
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
1 |
01/04/23 |
01/04/23 |
ASX - By Stock
|
1.2K
|
435K
|
1
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
0 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
1.2K
|
435K
|
0
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
2 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
1.2K
|
435K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
riskit
|
425 |
128K |
0 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
128K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
riskit
|
687 |
258K |
28 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
687
|
258K
|
28
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives regulatory approvals for cough counter
|
|
riskit
|
23 |
6.9K |
4 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
23
|
6.9K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
riskit
|
142 |
31K |
8 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
142
|
31K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
riskit
|
3.3K |
2.5M |
3 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
3
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
0 |
14/10/21 |
14/10/21 |
ASX - By Stock
|
1.2K
|
435K
|
0
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
1 |
21/08/21 |
21/08/21 |
ASX - By Stock
|
1.2K
|
435K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
riskit
|
3.3K |
2.5M |
4 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate enters licence agreement with ResApp Health
|
|
riskit
|
122 |
41K |
6 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
122
|
41K
|
6
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
1 |
25/06/21 |
25/06/21 |
ASX - By Stock
|
1.2K
|
435K
|
1
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
1 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
1.2K
|
435K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
riskit
|
4.6K |
2.2M |
5 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
4.6K
|
2.2M
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp appoints VP, Commercial to progress growth strategy
|
|
riskit
|
231 |
81K |
7 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
231
|
81K
|
7
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
0 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
1.2K
|
435K
|
0
|
|
ASX - By Stock
|
BGT |
Re:
News and media
|
|
riskit
|
592 |
164K |
4 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
592
|
164K
|
4
|
|
ASX - By Stock
|
BGT |
Re:
News and media
|
|
riskit
|
592 |
164K |
1 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
592
|
164K
|
1
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
2 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
1.2K
|
435K
|
2
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
2 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
1.2K
|
435K
|
2
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
1 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
1.2K
|
435K
|
1
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
0 |
06/03/21 |
06/03/21 |
ASX - By Stock
|
1.2K
|
435K
|
0
|
|
ASX - By Stock
|
AHI |
Re:
MYQ Chart
|
|
riskit
|
166 |
41K |
2 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
166
|
41K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: CE Mark achieved for wearable device
|
|
riskit
|
77 |
23K |
6 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
77
|
23K
|
6
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
2 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
1.2K
|
435K
|
2
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
1 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
1.2K
|
435K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Results and Investor Conference Call Notification
|
|
riskit
|
26 |
10K |
4 |
01/03/21 |
01/03/21 |
ASX - By Stock
|
26
|
10K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Board members - Its time to buy or go
|
|
riskit
|
172 |
49K |
8 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
172
|
49K
|
8
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
3 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
1.2K
|
435K
|
3
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
1 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
1.2K
|
435K
|
1
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
1 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
1.2K
|
435K
|
1
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
riskit
|
1.2K |
435K |
2 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
1.2K
|
435K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Board members - Its time to buy or go
|
|
riskit
|
172 |
49K |
7 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
172
|
49K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: SleepCheck Launched on Select Android Devices
|
|
riskit
|
129 |
49K |
4 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
129
|
49K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: SleepCheck Launched on Select Android Devices
|
|
riskit
|
129 |
49K |
7 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
129
|
49K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp strengthens patent position in Europe
|
|
riskit
|
16 |
5.6K |
3 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
16
|
5.6K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
riskit
|
314 |
83K |
9 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
314
|
83K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Results and Investor Conference Call Notification
|
|
riskit
|
26 |
10K |
2 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
26
|
10K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
riskit
|
314 |
83K |
50 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
314
|
83K
|
50
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
riskit
|
314 |
83K |
24 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
314
|
83K
|
24
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Results and Investor Conference Call Notification
|
|
riskit
|
26 |
10K |
15 |
28/01/21 |
28/01/21 |
ASX - By Stock
|
26
|
10K
|
15
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Further Positive Results Reinforce Environmental Safety
|
|
riskit
|
29 |
5.8K |
2 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
29
|
5.8K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
RAP - dec 2020 qtr revenue and share price prediction (
|
|
riskit
|
79 |
29K |
1 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
79
|
29K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
RAP - dec 2020 qtr revenue and share price prediction (
|
|
riskit
|
79 |
29K |
4 |
23/01/21 |
23/01/21 |
ASX - By Stock
|
79
|
29K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
riskit
|
245 |
66K |
0 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
245
|
66K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
How Phenix and Coviu Integration is doing?
|
|
riskit
|
42 |
16K |
13 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
42
|
16K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
How Phenix and Coviu Integration is doing?
|
|
riskit
|
42 |
16K |
17 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
42
|
16K
|
17
|
|